Geode Capital Management, LLC Vericel Corp Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Vericel Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,154,053 shares of VCEL stock, worth $65.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,154,053
Previous 1,144,440 0.84%
Holding current value
$65.2 Million
Previous $52.5 Million 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$42.25 - $53.56 $406,149 - $514,872
9,613 Added 0.84%
1,154,053 $48.8 Million
Q2 2024

Aug 09, 2024
BUY
$41.71 - $52.9 $3.36 Million - $4.26 Million
80,495 Added 7.57%
1,144,440 $52.5 Million
Q1 2024

May 13, 2024
BUY
$32.52 - $52.33 $1.19 Million - $1.91 Million
36,566 Added 3.56%
1,063,945 $55.3 Million
Q4 2023

Feb 13, 2024
BUY
$30.85 - $37.09 $1.55 Million - $1.86 Million
50,161 Added 5.13%
1,027,379 $36.6 Million
Q3 2023

Nov 13, 2023
BUY
$31.69 - $39.25 $1.07 Million - $1.32 Million
33,666 Added 3.57%
977,218 $32.8 Million
Q2 2023

Aug 11, 2023
BUY
$29.0 - $38.37 $1.27 Million - $1.68 Million
43,754 Added 4.86%
943,552 $35.4 Million
Q1 2023

May 15, 2023
BUY
$23.85 - $31.34 $869,785 - $1.14 Million
36,469 Added 4.22%
899,798 $26.4 Million
Q4 2022

Feb 13, 2023
BUY
$17.65 - $27.37 $536,577 - $832,075
30,401 Added 3.65%
863,329 $22.7 Million
Q3 2022

Nov 14, 2022
BUY
$22.62 - $32.54 $299,307 - $430,569
13,232 Added 1.61%
832,928 $19.3 Million
Q2 2022

Aug 12, 2022
SELL
$22.88 - $39.45 $265,019 - $456,949
-11,583 Reduced 1.39%
819,696 $20.6 Million
Q1 2022

May 13, 2022
BUY
$31.69 - $43.29 $643,465 - $879,003
20,305 Added 2.5%
831,279 $31.8 Million
Q4 2021

Feb 11, 2022
BUY
$35.2 - $52.6 $355,801 - $531,680
10,108 Added 1.26%
810,974 $31.9 Million
Q3 2021

Nov 12, 2021
BUY
$46.35 - $59.75 $141,738 - $182,715
3,058 Added 0.38%
800,866 $39.1 Million
Q2 2021

Aug 13, 2021
BUY
$47.2 - $67.81 $1.85 Million - $2.66 Million
39,209 Added 5.17%
797,808 $41.9 Million
Q1 2021

May 12, 2021
BUY
$30.93 - $59.48 $2.43 Million - $4.67 Million
78,430 Added 11.53%
758,599 $42.1 Million
Q4 2020

Feb 12, 2021
BUY
$18.53 - $31.5 $218,505 - $371,448
11,792 Added 1.76%
680,169 $21 Million
Q3 2020

Nov 13, 2020
SELL
$14.68 - $19.12 $196,359 - $255,749
-13,376 Reduced 1.96%
668,377 $12.4 Million
Q2 2020

Aug 13, 2020
BUY
$8.5 - $15.82 $149,991 - $279,159
17,646 Added 2.66%
681,753 $9.42 Million
Q1 2020

May 14, 2020
BUY
$7.25 - $19.22 $337,110 - $893,691
46,498 Added 7.53%
664,107 $6.09 Million
Q4 2019

Feb 13, 2020
BUY
$13.77 - $19.2 $205,104 - $285,984
14,895 Added 2.47%
617,609 $10.7 Million
Q3 2019

Nov 12, 2019
BUY
$14.93 - $19.83 $379,072 - $503,483
25,390 Added 4.4%
602,714 $9.13 Million
Q2 2019

Aug 14, 2019
BUY
$15.01 - $18.89 $458,915 - $577,542
30,574 Added 5.59%
577,324 $10.9 Million
Q1 2019

May 14, 2019
BUY
$16.23 - $20.29 $815,719 - $1.02 Million
50,260 Added 10.12%
546,750 $9.57 Million
Q4 2018

Feb 13, 2019
BUY
$10.77 - $18.44 $236,530 - $404,979
21,962 Added 4.63%
496,490 $8.64 Million
Q3 2018

Nov 13, 2018
BUY
$9.1 - $14.8 $356,001 - $578,990
39,121 Added 8.98%
474,528 $6.71 Million
Q2 2018

Aug 14, 2018
BUY
$9.6 - $14.6 $1.67 Million - $2.54 Million
174,131 Added 66.65%
435,407 $4.22 Million
Q1 2018

May 15, 2018
BUY
$5.7 - $12.3 $34,815 - $75,128
6,108 Added 2.39%
261,276 $2.6 Million
Q4 2017

Feb 13, 2018
BUY
$3.65 - $5.98 $99,374 - $162,811
27,226 Added 11.94%
255,168 $1.39 Million
Q2 2017

Aug 14, 2017
BUY
N/A
227,942
227,942 $752,000

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.5M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email